The Swiss Tropical and Public Health Institute is at the forefront of important research using Volumetric Absorptive Microsampling (VAMS®) technology and Mitra® microsampling devices in low-resourced regions. Recently, it tested Mitra® devices against more traditional Dried Blood Spot (DBS) cards in pediatric PK studies in rural Côte d’Ivoire.
In an era of change, labs are responding with new and innovative approaches and considering new angles from science and business perspectives. One Austin-based lab, focused on personalized medicine, merits special attention.
The California Initiative for the Advancement of Precision Medicine (CIAPM) is a national public entity formulated to ignite rational precision medicine research on popular diseases. It recently funded a study that will apply microsampling techniques. The upcoming multi-method, longitudinal, prospective cohort study will engage 200 patients with stable ischemic heart disease (IHD).
In its May 2018 recommendation, the Food and Drug Administration includes the use of dried blood spot sampling for biomedical validation. The future of clinical chemistry and pharmacology will emphasize the use of microsampling.
Doctors normally collect blood samples to understand, prevent, treat, and also monitor various conditions. You are familiar with the unnerving, painful, frightening, and inconvenient part of the blood-draw process. The inconvenience is caused when you have to leave your home or work to go to the lab. It doesn’t always have to be that way.
Vitamin D acts as an essential enhancer of phosphate and calcium homeostasis. Scientists are familiar with the role the hormone plays in the formation and maintenance of strong bones and teeth in vertebrates. As a hormone, it can be synthesized by the skin after prolonged exposure to sunlight. It is also obtained from a wide variety of animal products such as eggs, cheese, and milk.